199 related articles for article (PubMed ID: 15491694)
41. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists.
Kümmerlin I; ten Kate F; Smedts F; Horn T; Algaba F; Trias I; de la Rosette J; Laguna MP
Pathol Res Pract; 2009; 205(1):27-34. PubMed ID: 18930357
[TBL] [Abstract][Full Text] [Related]
42. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.
Cantwell CP; Wah TM; Gervais DA; Eisner BH; Arellano R; Uppot RN; Samir AE; Irving HC; McGovern F; Mueller PR
J Vasc Interv Radiol; 2008 Jul; 19(7):1034-40. PubMed ID: 18589317
[TBL] [Abstract][Full Text] [Related]
43. Minimally invasive treatment of renal cell carcinoma: comparison of 4 different monopolar radiofrequency devices.
Häcker A; Vallo S; Weiss C; Grobholz R; Alken P; Knoll T; Michel MS
Eur Urol; 2005 Oct; 48(4):584-92. PubMed ID: 16046053
[TBL] [Abstract][Full Text] [Related]
44. Acute tubular necrosis following radiofrequency ablation of a renal cell carcinoma.
Wah TM; Irving HC
Cardiovasc Intervent Radiol; 2009 May; 32(3):591-2. PubMed ID: 17985183
[TBL] [Abstract][Full Text] [Related]
45. Renal neoplasms amenable to partial nephrectomy: MR imaging.
Pretorius ES; Siegelman ES; Ramchandani P; Cangiano T; Banner MP
Radiology; 1999 Jul; 212(1):28-34. PubMed ID: 10405716
[TBL] [Abstract][Full Text] [Related]
46. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
Linden PA; Wee JO; Jaklitsch MT; Colson YL
Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
[TBL] [Abstract][Full Text] [Related]
47. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass.
Levinson AW; Su LM; Agarwal D; Sroka M; Jarrett TW; Kavoussi LR; Solomon SB
J Urol; 2008 Aug; 180(2):499-504; discussion 504. PubMed ID: 18550123
[TBL] [Abstract][Full Text] [Related]
48. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring.
Wingo MS; Leveillee RJ
J Endourol; 2008 Jun; 22(6):1261-7. PubMed ID: 18484892
[TBL] [Abstract][Full Text] [Related]
49. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.
Shannon BA; Cohen RJ; de Bruto H; Davies RJ
J Urol; 2008 Oct; 180(4):1257-61; discussion 1261. PubMed ID: 18707712
[TBL] [Abstract][Full Text] [Related]
50. Image-guided radiofrequency ablation (RFA) of spinal tumors.
Gevargez A; Groenemeyer DH
Eur J Radiol; 2008 Feb; 65(2):246-52. PubMed ID: 17524585
[TBL] [Abstract][Full Text] [Related]
51. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
[TBL] [Abstract][Full Text] [Related]
52. [Radio-frequency ablation of T1a renal cell carcinoma].
Fujito A; Kawauchi A; Yoneda K; Ukimura O; Miki T
Hinyokika Kiyo; 2005 Aug; 51(8):523-5. PubMed ID: 16164267
[TBL] [Abstract][Full Text] [Related]
53. Stimulated Raman histology as a method to determine the adequacy of renal mass biopsy and identify malignant subtypes of renal cell carcinoma.
Mannas MP; Deng FM; Belanger EC; Jones D; Ren J; Huang W; Orringer DA; Taneja SS
Urol Oncol; 2023 Jul; 41(7):328.e9-328.e13. PubMed ID: 37225634
[TBL] [Abstract][Full Text] [Related]
54. [Initial experience with radiofrequency percutaneous ablation of renal tumors].
Pascual Piédrola JI; Grasa Lanau V; Aldave Villanueva J; Arrondo Arrondo JL; Cuesta Alcalá JA; Ponz González M; Napal Lecumberri S; Solchaga Martínez A; Ipiens Aznar A
Arch Esp Urol; 2004 Dec; 57(10):1113-9. PubMed ID: 15714848
[TBL] [Abstract][Full Text] [Related]
55. Is radiofrequency ablation safe for solitary kidneys?
Jacobsohn KM; Ahrar K; Wood CG; Matin SF
Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
57. Radiofrequency ablation of large renal angiomyolipoma: median-term follow-up.
Gregory SM; Anderson CJ; Patel U
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):682-9. PubMed ID: 23354958
[TBL] [Abstract][Full Text] [Related]
58. Oncocytic papillary renal cell carcinoma with solid architecture: mimic of renal oncocytoma.
Mai KT; Kohler DM; Robertson SJ; Belanger EC; Marginean EC
Pathol Int; 2008 Mar; 58(3):164-8. PubMed ID: 18251779
[TBL] [Abstract][Full Text] [Related]
59. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies.
Clasen S; Krober SM; Kosan B; Aebert H; Fend F; Bomches A; Claussen CD; Pereira PL
Cancer; 2008 Dec; 113(11):3121-9. PubMed ID: 18973180
[TBL] [Abstract][Full Text] [Related]
60. Imaging and management of the incidentally discovered renal mass.
Willatt J; Francis IR
Cancer Imaging; 2009 Oct; 9 Spec No A(Special issue A):S30-7. PubMed ID: 19965291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
